Erschienen in:
31.08.2016 | Commentary
What is the truth about renin angiotensin blockers for diabetic patients?
verfasst von:
Atsuko Abiko
Erschienen in:
Diabetology International
|
Ausgabe 4/2016
Einloggen, um Zugang zu erhalten
Excerpt
Many type 2 diabetic patients have concomitant hypertension. These patients require treatment to maintain their blood pressure (BP) within acceptable ranges to decrease the risk of cardiovascular disease or diabetic nephropathy. Lowering BP can decrease the risk or slow the progression of diabetic nephropathy, and thus it is important to evaluate diabetic patients with albuminuria and perform proper staging of diabetic nephropathy. In the Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) study in 2009 [
1], of 11,140 patients with type 2 diabetes, those who achieved lower BP presented fewer renal events. …